[Federal Register Volume 61, Number 183 (Thursday, September 19, 1996)]
[Notices]
[Page 49351]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-23949]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 24, 1996, Eli Lilly 
Industries, Inc., Chemical Plant, Kilometer 146.7, State Road 2, 
Mayaguez, Puerto Rico 00680, made application to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of 
dextropropoxyphene, bulk (non-dosage forms) (9273) a basic class of 
controlled substance listed in Schedule II.
    The firm plans to manufacture bulk product for distribution to its 
customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than November 18, 1996.

    Dated: September 4, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-23949 Filed 9-18-96; 8:45 am]
BILLING CODE 4410-09-M